34.81
price up icon8.68%   2.78
after-market Handel nachbörslich: 35.13 0.32 +0.92%
loading

Finanzdaten der Monopar Therapeutics Inc-Aktie (MNPR)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - 0.0735
Operating Expenses
0.39%
3.2343
3.2218 11.07 1.5749 1.7888
Operating Income/Loss
0.39%
-3.2343
-3.2218 -11.07 -1.5749 -1.7888
Income/Loss From Continuing Operations Before Tax
6.53%
-2.4535
-2.625 -10.92 -1.3043 -1.7153
Income/Loss From Continuing Operations After Tax
6.53%
-2.4535
-2.625 -10.93 -1.3043 -1.7153
Net Income/Loss
6.53%
-2.4535
-2.625 -10.93 -1.3043 -1.7153
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.15%
6.9981
6.9874 0.3709 3.5204 17.51
Basic Earnings Per Share
7.89%
-0.35
-0.38 -2.75 -0.37 -0.10
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
Kapitalisierung:     |  Volumen (24h):